Ariad Pharmaceuticals Inc fka ARIA

[CowBoE]

What's same is possible blood clot issue in some patients that are sensitive to the drug.

What's not same is government investigation.

Right now, ARIA is punished for the worst outcome.

It could fall more, but I think the upside risk/reward
is pretty good at low $4s.

I.e., ARIA could tank to let's say $3 or even $2 or about 50% from here.

But the upside on any new positive findings such as lower dosage
being more safe and lift on FDA hold, could shoot this up to $15 to $20 for 400% to 500% gain.

I like this type of of risk/reward.

But you may have to hold for a period for this to develop
as company needs to come up with some remedy plan.

You might even wait past today for ARIA to settle in price.
Right now, aggressive shorts are doing all out attack.